A new treatment for hip osteoarthritis: Clinical evidence for the efficacy of autologous conditioned serum

Orthopedic Reviews

Volumn 5, Issue 2, 2013, Pages 59-64

  Baltzer, Axel W A ^a,b   Ostapczuk, Martin S ^c   Stosch, Daniel ^a,b   Seidel, Florian ^a,b   Granrath, Markus ^a,b  

^a Centre for Molecular Orthopaedics   (Germany)

^b Kinios Clinic Düsseldorf   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Autologous conditioned serum; Hip osteoarthritis; Recombinant IL 1 receptor antagonist protein

Indexed keywords

CORTISONE; CYTOKINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRIAM 10 LICHTENSTEIN; TRIAMCINOLONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOLOGOUS CONDITIONED SERUM; DRUG EFFICACY; FEMALE; HIP OSTEOARTHRITIS; HIP PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 84899808569     PISSN: 20358237     EISSN: 20358164     Source Type: Journal    
DOI: 10.4081/or.2013.e13     Document Type: Article

References (31)

1. Baltzer A, Moser C, Jansen S, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage 2009;17:152-60.
2. Richette P, Ravaud P, Conrozier T, et al. Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthritis Rheum 2009;60:824-30.
3. Sadowski T, Steinmeyer J. Effects of nonsteroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes. Osteoarthritis Cartilage 2001;9:407-15.
4. Kruse D. Intraarticular cortisone injection for osteoarthritis of the hip. Is it effective? Is it safe? Curr Rev Musculoskelet Med 2008;1:227-33.
5. Abate M, Pelotti P, De A, et al. Viscosupplementation with hyaluronic acid in hip osteoarthritis (a review). Ups J Med Sci 2008;113:261-77.
6. Fernandez L, Ruano-Ravina A. Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. Osteoarthritis Cartilage 2006;14:1306-11.
7. Chevalier X. Intraarticular treatments for osteoarthritis: new perspectives. Curr Drug Targets 2010;11:546-60.
8. Evans CH, Ghivizzani SC, Robbins PD. Getting arthritis gene therapy into the clinic. Nat Rev Rheumatol 2010;7:244-9.
9. Kraus V, Birmingham J, Stabler T, et al. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage 2012;20:271-8.
10. Frisbie DD, Ghivizzani SC, Robbins PD, et al. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 2002;9:12-20.
11. Fernandes J, Tardif G, Martel-Pelletier J, et al. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol 1999;154:1159-69.
12. Rutgers M, Saris DBF, Dhert WJA, Creemers LB. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection. Arthritis Res Ther 2010;12:R114.
13. Wehling P, Reinecke J, Baltzer A, et al. Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis. Hum Gene Ther 2009;20:97-101.
14. Burmester GR, Grifka J. [Revision of the recommendations of the Commission on the Pharmacotherapy of the German Society for Rheumatology. Comment on the use of Orthokin]. Z Rheumatol 2007;66:83-4. [Article in German]
15. Frisbie D, Kawcak C, Werpy N, et al. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res 2007;68:290-6.
16. Yang K, Raijmakers NJ, van Arkel ER, et al. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthritis Cartilage 2008;16:498-505.
17. Evans C. Novel biological approaches to the intra-articular treatment of osteoarthritis. Bio Drugs 2005;19:355-62.
18. Bresnihan B, Cobby M. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Rheumatology (Oxford) 2003;42 Suppl 2:ii22-8.
19. Chevalier X, Giraudeau B, Conrozier T, et al. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. J Rheumatol 2005;32: 1317-23.
20. Bacconnier L, Jorgensen C, Fabre S. Erosive osteoarthritis of the hand: clinical experience with anakinra. Ann Rheum Dis 2009;68:1078-9.
21. Goupille P, Mulleman D, Chevalier X. Is interleukin-1 a good target for therapeutic intervention in intervertebral disc degeneration: lessons from the osteoarthritic experience. Arthritis Res Ther 2007;9:110.
22. Gravetter FJ, Forzano LB. Research methods for the behavioral sciences. 3rd ed. Belmont, CA: Wadsworth Cenage Learning; 2009.
23. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
24. Freyd M. The graphic rating scale. J Educ Psychol 1923;14:83-102.
25. Goldsmith CH, Boers M, Bombardier C, Tugwell P. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol 1993;20:561-5.
26. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Psychology Press; 1988.
27. Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-91.
28. Horng S, Miller FG. Is placebo surgery unethical? N Engl J Med 2002;347:137-9.
29. Cobb LA, Thomas GI, Dillard DH, et al. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med 1959;260:1115-8.
30. Moseley JB, O'Malley K, Petersen NJ, et al. Controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002;347:81-8.
31. Schnitzer T, Dattani I, Seriolo B, et al. A 13-week, multicenter, randomized, doubleblind study of lumiracoxib in hip osteoarthritis. Clin Rheumatol 2011;30: 1433-46.